---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-009538"
form_type: "8-K"
ticker: "LPCN"
cik: "0001535955"
company_name: "Lipocine Inc."
filed_at: "2022-04-11T23:59:59+00:00"
generated_at: "2026-06-26T08:13:26.790124+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Lipocine appoints Jill M. Jene and Spyros Papapetropoulos to board of directors

## Summary
- Board expanded to six members; Dr. Jene and Dr. Papapetropoulos appointed effective April 11, 2022.
- Both are independent directors under Nasdaq rules; Dr. Jene will serve on Audit Committee, Dr. Papapetropoulos on Compensation Committee.
- Each new director receives an initial option grant for 10,000 shares and $35,000 annual retainer plus $5,000 for committee service.
- Dr. Jene brings over 20 years of biopharma strategy and deal-making; Dr. Papapetropoulos has neuroscience expertise and experience as CMO at multiple firms.

## SEC filing metadata
- accession: 0001493152-22-009538
- form_type: 8-K
- ticker: LPCN
- cik: 0001535955
- company_name: Lipocine Inc.
- filed_at: 2022-04-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1535955/000149315222009538/0001493152-22-009538-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1535955/000149315222009538/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-009538
- JSON: https://secwatch.observer/filing/0001493152-22-009538.json
- Plain text: https://secwatch.observer/filing/0001493152-22-009538.txt

## Key facts
- Executive change
  Jill M. Jene was appointed as Director at Lipocine Inc..
  - Action: appointed
  - Role: Director
  source text: On April 11, 2022, the Board of Directors of the Company expanded the Board of Directors to six members and appointed Dr. Jill M. Jene and Dr. Spyros Papapetropoulos as directors, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1535955/000149315222009538/0001493152-22-009538-index.htm
- Executive change
  Spyros Papapetropoulos was appointed as Director at Lipocine Inc..
  - Action: appointed
  - Role: Director
  source text: On April 11, 2022, the Board of Directors of the Company expanded the Board of Directors to six members and appointed Dr. Jill M. Jene and Dr. Spyros Papapetropoulos as directors, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1535955/000149315222009538/0001493152-22-009538-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.